|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Didkowska J, Wojciechowska U, Mańczuk M
and Łobaszewski J: Lung cancer epidemiology: Contemporary and
future challenges worldwide. Ann Transl Med. 4:1502016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research. Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumor Biol. 36:2947–2955. 2015. View Article : Google Scholar
|
|
10
|
Gao K, Ji Z, She K, Yang Q and Shao L:
Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and
promotes glioma cell progression by activation of the Notch
signaling pathway. Biomed Pharmacother. 87:555–560. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Hu N, Wang C, Zhao H and Gu Y:
Long non-coding RNA CCAT1 promotes multiple myeloma progression by
acting as a molecular sponge of miR-181a-5p to modulate HOXA1
expression. Cell Cycle. 17:319–329. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun CC, Zhang L, Li G, Li SJ, Chen ZL, Fu
YF, Gong FY, Bai T, Zhang DY, Wu QM and Li DJ: The lncRNA PDIA3P
interacts with miR-185-5p to modulate oral squamous cell carcinoma
progression by targeting cyclin D2. Mol Ther-Nucleic Acids.
9:100–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang X, Ye H, He M, Zhou X, Sun N, Guo W,
Lin X, Huang H, Lin Y, Yao R and Wang H: LncRNA PDIA3P interacts
with c-Myc to regulate cell proliferation via induction of pentose
phosphate pathway in multiple myeloma. Biochem Biophys Res Commun.
498:207–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang FQ, Zhang HM, Chen SJ, Yan Y and
Zheng JH: MiR-506 is down-regulated in clear cell renal cell
carcinoma and inhibits cell growth and metastasis via targeting
FLOT1. PLoS One. 10:e01202582015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ou L, Wang D, Zhang H, Yu Q and Hua F:
Decreased expression of MiR-138-5p by LncRNA H19 in cervical cancer
promotes tumor proliferation. Oncol Res. 26:401–410. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gu Y, Xiao X and Yang S: LncRNA MALAT1
acts as an oncogene in multiple myeloma through sponging miR-509-5p
to modulate FOXP1 expression. Oncotarget. 8:101984–101993. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tu J, Yu Y, Liu W and Chen S: Significance
of human epidermal growth factor receptor 2 expression in
colorectal cancer. Exp Ther Med. 9:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pridgeon MG, Grohar PJ, Steensma MR and
Williams BO: Wnt signaling in ewing sarcoma, osteosarcoma, and
malignant peripheral nerve sheath tumors. Curr Osteoporosis Rep.
15:239–246. 2017. View Article : Google Scholar
|
|
20
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng WX, Koirala P and Mo Y:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Q, Ni Z, Cheng Z, Xu J, Yu H and Yin
P: Three circulating long non-coding RNAs act as biomarkers for
predicting NSCLC. Cell Physiol Biochem. 37:1002–1009. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu
FQ, Hu R and Wang MS: LncRNA HMlincRNA717 is down-regulated in
non-small cell lung cancer and associated with poor prognosis. Int
J Clin Exp Pathol. 7:8881–8886. 2014.PubMed/NCBI
|
|
25
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
26
|
Gao X, Zhao S, Yang X, Zang S and Yuan X:
Long non-coding RNA FLVCR1-AS1 contributes to the proliferation and
invasion of lung cancer by sponging miR-573 to upregulate the
expression of E2F transcription factor 3. Biochem Biophys Res
Commun. 505:931–938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
MacDonald BT, Tamai K and He X:
Wnt/Beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao H, Hou W, Tao J, Zhao Y, Wan G, Ma C
and Xu H: Upregulation of lncRNA HNF1A-AS1 promotes cell
proliferation and metastasis in osteosarcoma through activation of
the Wnt/β-catenin signaling pathway. Am J Transl Res. 8:3503–3512.
2016.PubMed/NCBI
|
|
31
|
Huang SM, Mishina YM, Liu S, Cheung A,
Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner
S, et al: Tankyrase inhibition stabilizes axin and antagonizes Wnt
signalling. Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
